The chemokines CXCL9 and CCL20 have been reported to be associated with ventricular dysfunction. This study was aimed to investigate the effects of CXCL9/CCL20 on cardiac fibrosis following myocardial infarction (MI). Blood samples of patients with MI were obtained to determine the serum CXCL9, CCL20, tumor necrosis factor-α (TNF-α), and transforming growth factor-β (TGF-β). The expression of CXCL9 and CCL20 in hypoxia-incubated H9c2 cells and TNF-α/TGF-β-activated peripheral blood mononuclear cells (PBMCs) were examined. The experimental MI of rats was produced by the intraperitoneal injection of isoproterenol (ISO) (85 mg/kg/day) for two consecutive days. The growth and migration of CXCL9/CCL20-incubated cardiac fibroblasts in vitro were evaluated. TNF-α/TGF-β-activated PBMCs showed an enhanced expression of CXCL9 and CCL20, while hypoxic H9c2 cells did not. Patients with MI had significantly enhanced levels of serum TGF-β and CXCL9 compared to healthy subjects. ISO-treated rats had increased serum CXCL9 levels and marked cardiac fibrosis compared to control rats. The trend of increased serum CCL20 in patients with MI and ISO-treated rats was not significant. CXCL9-incubated cardiac fibroblasts showed enhanced proliferation and migration. The findings of this study suggest that an enhanced expression of CXCL9 following MI might play a role in post-MI cardiac fibrosis by activating cardiac fibroblasts.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572441 | PMC |
| http://dx.doi.org/10.3390/jcm8050659 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Establishment of a 3D multi-layered in vitro model of inflammatory bowel disease.
J Control Release
January 2025
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IUCS-CESPU - Instituto Universitário de Ciências da Saúde, Rua Central de Gandra 1317, 4585-116 Gandra, Portugal. Electronic address:
Article Synopsis
- Crohn's Disease and Ulcerative Colitis are serious gastrointestinal disorders that currently have no cure, emphasizing the need for better research models to test new therapies.
- A new three-dimensional (3D) in vitro model mimics the IBD environment by incorporating multiple layers of tissue and immune responses, which includes human intestinal cells and macrophages.
- This innovative model allows for inducing inflammation similar to that seen in IBD, improving drug testing accuracy and potentially reducing reliance on animal studies while aiding in the understanding of disease mechanisms.
Protein kinase D1 in myeloid lineage cells contributes to the accumulation of CXCR3CCR6 nonconventional Th1 cells in the lungs and potentiates hypersensitivity pneumonitis caused by .
Front Immunol
October 2024
Integrated Biomedical Science Graduate Program, The University of Tennessee Health Science Center, Memphis, TN, United States.
Article Synopsis
- Hypersensitivity pneumonitis (HP) is an allergic lung condition characterized by inflammation and granuloma formation; recent studies suggest that protein kinase D1 (PKD1) in lungs contributes to its acute inflammation and IL-17A expression.
- The study utilized mouse models exposed to specific allergens to examine the effects of PKD1 in myeloid-lineage cells on HP development by measuring immune responses and tissue changes.
- Results indicated that mice lacking PKD1 in myeloid cells showed reduced inflammation and cytokine levels, leading to less lung damage and immune cell accumulation compared to normal mice, highlighting PKD1’s importance in HP progression.
JAML overexpressed in colorectal cancer promotes tumour proliferation by activating the PI3K-AKT-mTOR signalling pathway.
Sci Rep
October 2024
Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, People's Republic of China.
Article Synopsis
- JAML was found to be overexpressed in 50% of the tissues analyzed, linked to more advanced cancer stages, and patients with high JAML expression showed poorer overall survival rates.
- The research suggests that JAML enhances CRC cell growth and invasion by activating the PI3K-AKT-mTOR signaling pathway while reducing tumor-infiltrating lymphocytes (TILs), indicating its potential as a therapeutic target for CRC treatment.
Orally administered yeast-derived β-glucan alleviates mast cell-dependent airway hyperresponsiveness and inflammation in a murine model of asthma.
Immun Inflamm Dis
June 2024
Laboratory of Oncology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Medical Center, Basic Research Center, Changzhou, China.
Background: Particulate β-glucans (WGP) are natural compounds with regulatory roles in various biological processes, including tumorigenesis and inflammatory diseases such as allergic asthma. However, their impact on mast cells (MCs), contributors to airway hyperresponsiveness (AHR) and inflammation in asthma mice, remains unknown.
Methods: C57BL/6 mice underwent repeated OVA sensitization without alum, followed by Ovalbumin (OVA) challenge.
RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease.
Clin Immunol
August 2024
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address:
Article Synopsis
- Systemic lupus erythematosus is an autoimmune disease causing damage to kidneys and organs, which was studied in the context of nephrotoxic nephritis (NTN) as a model for lupus nephritis.
- The research focused on response gene to complement-32 (RGC-32), finding that its absence in RGC-32 knockout (KO) NTN mice led to reduced proteinuria, improved kidney function, and less severe kidney damage.
- RGC-32 KO mice also showed decreased recruitment of certain immune cells and less renal fibrosis, suggesting that RGC-32 could be a promising target for new treatments aimed at combatting conditions like lupus nephritis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!